141 related articles for article (PubMed ID: 11025699)
1. Phase II study of paclitaxel and cisplatin for advanced urothelial cancer.
Burch PA; Richardson RL; Cha SS; Sargent DJ; Pitot HC; Kaur JS; Camoriano JK
J Urol; 2000 Nov; 164(5):1538-42. PubMed ID: 11025699
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
Kyriakakis Z; Dimopoulos MA; Kostakopoulos A; Karayiannis A; Sofras F; Zervas A; Giannopoulos A; Dimopoulos C
J Urol; 1997 Aug; 158(2):408-11. PubMed ID: 9224313
[TBL] [Abstract][Full Text] [Related]
3. Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
Kouno T; Ando M; Yonemori K; Matsumoto K; Shimizu C; Katsumata N; Komiyama M; Okajima E; Matsuoka N; Fujimoto H; Fujiwara Y
Eur Urol; 2007 Oct; 52(4):1115-22. PubMed ID: 17433855
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
Lin CC; Hsu CH; Huang CY; Cheng AL; Vogelzang NJ; Pu YS
J Urol; 2007 Jan; 177(1):84-9; discussion 89. PubMed ID: 17162009
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group.
Kitamura H; Taguchi K; Kunishima Y; Yanase M; Takahashi A; Shigyo M; Tanaka T; Mutoh M; Fukuta F; Masumori N; Tsukamoto T
Cancer Sci; 2011 Jun; 102(6):1171-5. PubMed ID: 21323791
[TBL] [Abstract][Full Text] [Related]
6. M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.
Igawa M; Kadena H; Ueda M; Usui T
Cancer Chemother Pharmacol; 1994; 35 Suppl():S1-4. PubMed ID: 7527732
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma.
Mulatero C; McClaren BR; Mason M; Oliver RT; Gallagher CJ
Br J Cancer; 2000 Dec; 83(12):1612-6. PubMed ID: 11104554
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens.
Joung JY; Kwon WA; Cho IC; Kim EK; Park S; Yoon H; Seo HK; Chung J; Park WS; Lee KH
Int J Urol; 2011 May; 18(5):350-7. PubMed ID: 21355894
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant methotrexate, vinblastine and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience.
Wei CH; Hsieh RK; Chiou TJ; Chen KK; Chang LS; Chen PM
J Urol; 1996 Jan; 155(1):118-21. PubMed ID: 7490806
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group.
Moore MJ; Winquist EW; Murray N; Tannock IF; Huan S; Bennett K; Walsh W; Seymour L
J Clin Oncol; 1999 Sep; 17(9):2876-81. PubMed ID: 10561365
[TBL] [Abstract][Full Text] [Related]
11. [Sequential methotrexate and 5-fluorouracil, doxorubicin, and cisplatin for advanced urothelial cancer].
Nishiyama T; Sasagawa T; Tanikawa T; Katayama Y; Kawakami Y; Tomita Y; Terunuma M; Kimura M; Sato S; Osawa T
Nihon Hinyokika Gakkai Zasshi; 1992 Mar; 83(3):352-7. PubMed ID: 1564837
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study.
Ko YJ; Canil CM; Mukherjee SD; Winquist E; Elser C; Eisen A; Reaume MN; Zhang L; Sridhar SS
Lancet Oncol; 2013 Jul; 14(8):769-76. PubMed ID: 23706985
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group Study.
Dreicer R; Manola J; Roth BJ; Cohen MB; Hatfield AK; Wilding G
J Clin Oncol; 2000 Mar; 18(5):1058-61. PubMed ID: 10694557
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of combination chemotherapy of methotrexate, epirubicin and nedaplatin (MEN) in patients with advanced urothelial carcinoma].
Hattori Y; Takizawa A; Kishida T; Kakizoe M; Fujikawa N; Teranishi J; Kondo K; Saito K; Noguchi K; Nakaigawa N; Kubota Y
Gan To Kagaku Ryoho; 2007 May; 34(5):739-43. PubMed ID: 17496448
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study.
Vaishampayan UN; Faulkner JR; Small EJ; Redman BG; Keiser WL; Petrylak DP; Crawford ED
Cancer; 2005 Oct; 104(8):1627-32. PubMed ID: 16138364
[TBL] [Abstract][Full Text] [Related]
16. CMV chemotherapy for advanced transitional cell carcinoma.
Jeffery GM; Mead GM
Br J Cancer; 1992 Sep; 66(3):542-6. PubMed ID: 1520591
[TBL] [Abstract][Full Text] [Related]
17. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules.
Bajorin DF; McCaffrey JA; Dodd PM; Hilton S; Mazumdar M; Kelly WK; Herr H; Scher HI; Icasiano E; Higgins G
Cancer; 2000 Apr; 88(7):1671-8. PubMed ID: 10738226
[TBL] [Abstract][Full Text] [Related]
19. Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancer.
Bellmunt J; Cos J; Clèries R; Pérez M; Ribas A; Eres N; Murio JE; Margarit C; Baselga J
Cancer Invest; 2002; 20(5-6):673-85. PubMed ID: 12197223
[TBL] [Abstract][Full Text] [Related]
20. [M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced renal pelvic and ureteral carcinoma].
Igawa M; Ueki T; Ueda M; Okada K; Usui T; Ohnishi Y; Kume T; Masu C; Ishino T; Nakatsu H
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2577-82. PubMed ID: 2673046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
